Zeton., a global leader in the design and fabrication of lab-scale systems, pilot plants, demonstration plants, and small production plants, proudly announces the official launch of its groundbreaking product, ContiUnity®, at the ACHEMA 2024 exhibition in Frankfurt am Main from June 10 to 14, 2024.
ContiUnity® revolutionizes modern medicine production by offering a scalable solution that can adapt to the industry’s evolving demands. Its modular design in both physical hardware and process control enables quick reconfiguration and adjustment to new processes without requiring extensive redesign and revalidation. This ensures the highest standards of quality and efficiency while minimizing downtime and costs. Each module is pre-validated and equipped with a local controller, providing optimum flexibility and real-time process control.
Modular design
ContiUnity® revolutionizes modern medicine production by offering a scalable solution that can adapt to the industry’s evolving demands.. The system’s modular design allows for rapid reconfiguration and adaptation to new processes without the need for extensive redesign and revalidation. This ensures the highest standards of quality and efficiency while minimizing downtime and reducing costs. Each module is pre-validated and equipped with a local controller, providing optimum flexibility and real-time process control.
Meet us at the ACHEMA
ACHEMA, the world forum for the process industries, is the perfect stage for Zeton to unveil ContiUnity®. Attendees at the ACHEMA 2024 will have the opportunity to witness live demonstrations of the ContiUnity® system and engage with Zeton’s team of experts to learn how this innovative solution can revolutionize pharmaceutical manufacturing.
Zeton has been at the forefront of modular system design, helping clients worldwide bring their unique process technologies to market efficiently and cost-effectively. With over 1,000 completed projects in 45 countries, Zeton’s team of over 350 dedicated employees operates from state-of-the-art facilities in Oakville, Ontario, Canada, and Enschede, the Netherlands.
